Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Graham Jackson

Newcastle AuthorsTitleYearFull text
Professor Graham Jackson
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial2021
Professor Graham Jackson
Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial2021
Professor Graham Jackson
Professor Marcus Kaiser
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma2021
Professor Graham Jackson
Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation2021
Professor Graham Jackson
BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma2020
Professor Graham Jackson
An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics2020
Dr Laura Jardine
Dr Urszula Cytlak-Chaudhuri
Dr Merry Gunawan
Dr Gary Reynolds
Dr Kile Green
et al.
Donor monocyte-derived macrophages promote human acute graft-versus-host disease2020
Professor Graham Jackson
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels2020
Dr Aneta Mikulasova
Professor Graham Jackson
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma2020
Professor Graham Jackson
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients2020